Cargando…
AC093797.1 as a Potential Biomarker to Indicate the Prognosis of Hepatocellular Carcinoma and Inhibits Cell Proliferation, Invasion, and Migration by Reprogramming Cell Metabolism and Extracellular Matrix Dynamics
Purpose: The risk signature composed of four lncRNA (AC093797.1, POLR2J4, AL121748.1, and AL162231.4.) can be used to predict the overall survival (OS) of patients with hepatocellular carcinoma (HCC). However, the clinical significance and biological function of AC093797.1 are still unexplored in HC...
Autores principales: | Liu, Xiaoling, Wang, Chenyu, Yang, Qing, Yuan, Yue, Sheng, Yunjian, Li, Decheng, Ojha, Suvash Chandra, Sun, Changfeng, Deng, Cunliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678093/ https://www.ncbi.nlm.nih.gov/pubmed/34925460 http://dx.doi.org/10.3389/fgene.2021.778742 |
Ejemplares similares
-
THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
por: Ding, Yuxi, et al.
Publicado: (2022) -
Association of STAT3 and STAT4 polymorphisms with susceptibility to chronic hepatitis B virus infection and risk of hepatocellular carcinoma: a meta-analysis
por: Shi, Han, et al.
Publicado: (2019) -
Antimicrobial peptidase lysostaphin at subinhibitory concentrations modulates staphylococcal adherence, biofilm formation, and toxin production
por: Yue, Yuan, et al.
Publicado: (2023) -
Investigational drugs with dual activity against HBV and HIV (Review)
por: Sun, Shiyu, et al.
Publicado: (2021) -
LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)